Glycyl-L-histidyl-L-lysine-Cu2+ attenuates cigarette smoke-induced pulmonary emphysema and inflammation by reducing oxidative stress pathway.

Study summary

Main finding

GHK-Cu reduced selected emphysema, inflammatory, and oxidative-stress measures with changes in NF-kappaB and Nrf2 signaling.

What was studied: Smoke-exposed mice and cultured human alveolar cells
How the study was set up: Mice exposed to cigarette smoke for 12 weeks and cultured human lung cells were studied with GHK-Cu comparisons.
What the researchers measured: Lung tissue changes, inflammatory and oxidative-stress markers, matrix-remodeling balance, and NF-κB/Nrf2 signaling were assessed.
How to read this evidence: Researchers studied cells, isolated tissue, or animals. These experiments can help explain a mechanism, but do not establish benefits or safety in people. Human cells grown in a laboratory also belong in this category.

Changes in a smoke-exposure model do not establish prevention or treatment of COPD in people. Human cell cultures remain preclinical evidence.

Animal exposure and cultured human cells do not establish clinical COPD treatment or human safety.

Why this paper is included: Smoking-exposed mouse and lung-cell experiments directly tested the GHK-Cu copper complex.
Publication indexing: Journal Article
Source checked: October 4, 2026. Years follow journal issues; online-first dates may differ.

Educational research information. A publication does not verify the identity, quality, or safety of products sold here.

Study summary

GHK-Cu reduced selected emphysema, inflammatory, and oxidative-stress measures with changes in NF-kappaB and Nrf2 signaling.

What was studied: Smoke-exposed mice and cultured human alveolar cells
How the study was set up: Mice exposed to cigarette smoke for 12 weeks and cultured human lung cells were studied with GHK-Cu comparisons.
What the researchers measured: Lung tissue changes, inflammatory and oxidative-stress markers, matrix-remodeling balance, and NF-κB/Nrf2 signaling were assessed.
How to read this evidence: Researchers studied cells, isolated tissue, or animals. These experiments can help explain a mechanism, but do not establish benefits or safety in people. Human cells grown in a laboratory also belong in this category.

Changes in a smoke-exposure model do not establish prevention or treatment of COPD in people. Human cell cultures remain preclinical evidence.

Animal exposure and cultured human cells do not establish clinical COPD treatment or human safety.

Why this paper is included: Smoking-exposed mouse and lung-cell experiments directly tested the GHK-Cu copper complex.
Publication indexing: Journal Article
Source checked: October 4, 2026. Years follow journal issues; online-first dates may differ.

Educational research information. A publication does not verify the identity, quality, or safety of products sold here.